All stocks / HRGN
Harvard Apparatus Regenerative Technology, Inc. HRGN
Harvard Apparatus Regenerative Technology (HRGN): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- HARVARD APPARATUS REGENERATIVE
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- Nov 16
The financial report, and what it means
Annual figures to 2025-12-31- Revenue
- $704,000
- Net loss
- ($6,869,000)
It spends more than it earns
Under strainCustomers paid it $704,000 in the year. It lost $6.9 million. For every $1 that came in, about $10.76 went out.
- Cash and cash equivalents
- $1,352,000
- Net cash used in operating activities
- ($3,828,000)
The cash could run out soon
Under strainIt had $1.4 million in the bank and used about $319,000 a month. At that pace the money lasts about 4 months unless it borrows or sells more shares.
- Total assets
- $2,677,000
- Total liabilities
- $1,620,000
It owns more than it owes
SteadyEverything the company owns adds up to $2.7 million. Its debts and unpaid bills add up to $1.6 million. That is about $0.61 owed for every $1 owned.
What this adds up to
2 of 3 checks show strain. It spends more than it earns. The cash could run out soon. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 18,761,064 shares as of 2026-11-02: 20,093,994 outstanding minus 1,332,930 held by 1 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about HRGN
Does HRGN file reports with the SEC?
Yes. Harvard Apparatus Regenerative Technology files with the SEC under company number 0001563665. The most recent filing we hold is a 10-Q dated 2026-11-13.
Source recordHow many HRGN shares are outstanding?
20,093,994 shares as of 2026-11-02, as reported to the SEC.
Source recordHas HRGN filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Who runs Harvard Apparatus Regenerative Technology?
Officers named in its insider filings: Junli He (CEO).
Source recordIs Harvard Apparatus Regenerative Technology making money?
Customers paid it $704,000 in the year. It lost $6.9 million. For every $1 that came in, about $10.76 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record